Inactief instrument

Andere talen Sunshine Heart Inc Nasdaq

Aandelen

US86782U1060

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida	14/05
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy	09/05
Top Midday Gainers	07/05
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.9M, vs. Street Est of $2M	07/05
Nuwellis, Inc. Announces First Quarter 2024 Financial Results	07/05
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	02/05
Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	02/05
Nuwellis Announces Closing of $2.7 Million Public Offering	01/05
Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024	30/04
Nuwellis Announces Pricing of $2.7 Million Public Offering	26/04
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	09/04
Nuwellis, Inc. Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	09/04
Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference	07/03
Nuwellis, Inc. Announces Results from Two New Clinical Data Analyses from the AVOID-HF Trial, Which Demonstrate the Benefits of its Aquadex System in Reducing Heart Failure Readmissions at 30 Days	07/03
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	06/03
Earnings Flash (NUWE) NUWELLIS Reports Q4 Revenue $2.6M	05/03
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results	05/03
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	27/02
Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™	22/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sunshine Heart Inc Nasdaq

Aandelen

US86782U1060

Andere talen

Filters